Please login to the form below

Not currently logged in
Email:
Password:

patient-centric

This page shows the latest patient-centric news and features for those working in and with pharma, biotech and healthcare.

Ipsen buys rare disease group Clementia in $1.3bn deal

Ipsen buys rare disease group Clementia in $1.3bn deal

We look forward to working closely with Clementia to successfully integrate two companies that share a similar patient-centric culture and the ambition to deliver new treatments to patients with unmet

Latest news

More from news
Approximately 0 fully matching, plus 87 partially matching documents found.

Latest Intelligence

  • From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality

    In response to patient-centric directives, the International Society for Medical Publication Professionals (ISMPP), the global not-for-profit organisation for medical publication professionals, engaged in educational activities on patient

  • The Pharma Brand Planners’ Blog: Part 1 The Pharma Brand Planners’ Blog: Part 1

    Speaking of patients…. How patient-centric is your plan? Is your target patient front and centre in your plan? ... Yet spending time on the right analysis, research, insights and planning time are vital: without them you can’t hope to create the very

  • The first, my last, my everything The first, my last, my everything

    Success is less about being ‘patient-centric’ and more about thinking ‘patients first’. ... That may require some organisations to rethink their approach. “In the future, companies may not have any choice but to be patient-centric – but

  • The importance of co-creation with patients The importance of co-creation with patients

    within the pharmaceutical industry towards patient-centric modes of working. ... Similarly, the concept of co-creation should be accepted as good practice within a patient-centric approach, but is not yet a routine way of working.

  • Cell and gene therapy Cell and gene therapy

    patient.”. Althoff cites Novartis’ Kymriah (tisagenlecleucel), a blood cancer cell therapy approved in Europe and the US last year, as an example of the differing manufacturing costs. ... Novartis has also adopted a more patient- and

More from intelligence
Approximately 0 fully matching, plus 67 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 24 fully matching, plus 63 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics